🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multi-center, open-label, single-arm, non-randomized phase ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2022-02-01
Trial ID
NCT05200312
The trial is an open-label, multi-center safety and preliminary efficacy tr...
Status
Active Not Recruiting
Location
Tohoku University Hoaspital
Start Date
2020-08-20
Trial ID
NCT04542824
This trial will compare tisagenlecleucel to standard of care in adult parti...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-10-02
Trial ID
NCT05888493
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Liso-ce...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03-29
Trial ID
NCT06313996
The purpose of this trial is to measure the safety and effectiveness of epc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-11-03
Trial ID
NCT04663347
Treatments Being Tested
Follicular lymphoma (FL) is the second most common B-cell cancer and the mo...
Status
Active Not Recruiting
Location
UCSF Fresno /ID# 264712
Start Date
2024-02-05
Trial ID
NCT06191744
To evaluate the efficacy and safety of lenalidomide, rituximab, cyclophosph...
Status
Completed
Location
Local Institution - 177
Start Date
2015-02-17
Trial ID
NCT02285062
Treatments Being Tested
The goal of this clinical study is test how well the study drug, axicabtage...
Status
Active Not Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2022-09-22
Trial ID
NCT05371093
In this phase II study, the investigators are aiming to explore lenalidomid...
Status
Completed
Location
270 Dongan Road, Fudan University Shanghai Cancer Center
Start Date
2019-10-22
Trial ID
NCT04164368
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells ...
Status
Active Not Recruiting
Location
The Fifth Medical Center of PLA General Hospital /ID# 230520
Start Date
2022-03-10
Trial ID
NCT05201248
Treatments Being Tested